clinical maestro case study q42018 - strategikonpharma.com
Post on 03-Feb-2022
2 Views
Preview:
TRANSCRIPT
2
RFP Process of a Phase 3 Clinical Trial for Neurodegenerative Rare Disease using Clinical Maestro Modular Applications
Client: Bay-area based Mid-Sized Biotech
STUDY: Phase 3 study with 80 sites, 600 patients, 21 countries
Training and support was provided to both Sponsor and CRO teams throughout the exercise.
Client created an electronic RFP from in SOURCE Application.
Bidders (CROs) were set-up in the VISION application for bid and contract management.
INITIATE RFPUsing SOURCE, four CROs were invited to bid directly in Clinical MaestroTM.
The bid due diligence, provider scoring and contract award were conducted in Clinical MaestroTM.
BID to CONTRACT
A pre-RFP clinical trial budget wasbuilt in Clinical MaestroTM
PORTFOLIO using our proprietary INTELLIGENCE BANK.
Baseline budget was leveraged to negotiate bids during outsourcing process.
PLAN and BUDGET
CASE STUDY
Results
•The Study Budget created in PORTFOLIO was 98% of the median budgets proposed by the CROs.•The sourcing of the Study was completed in 100 fewer hours, or 84% faster using the Clinical Maestro SOURCE module over traditional sourcing tools (Word, Excel, e-mail).
Strategikon Pharma
Operational Plan
Baseline Budget
3 Budget Scenarios
Generate RFP
Send RFP
Communication w. CRO
Budget Due Diligence
Weighting and Scoring Bids
12.5hours 25hours 37.5hours 50hours
8
24
8
24
16
40
1
8
3
3
2
2
Clinical Maestro Traditional
X
Results: Eff iciency
No difference
No difference
95% faster
88% faster
The sourcing of the Study was completed in 101 fewer hours, or 84% faster using the Clinical MaestroTM SOURCE module over traditional sourcing
tools (Word, Excel, e-mail).
88% faster
63% faster
67% faster
88% faster
Hours
top related